The Hong Kong dollar interbank interest rates all fell, with the one-month interbank interest rate falling for three consecutive days to 3.16131%.
On November 5th, Hong Kong dollar interbank rates fell across the board. The one-month interbank rate related to mortgage loans fell for the third consecutive day to 3.16131%, dropping by 15.369 basis points and reaching an eight-week low.
On November 5th, the Hong Kong Dollar Interbank Offered Rate (HIBOR) fell across the board, with the overnight rate dropping by 22.227 basis points to 2.57464%. The one-week HIBOR also fell by 28.702 basis points to 2.78929%, while the two-week rate dropped by 26.154 basis points to 2.8681%. The one-month HIBOR, which is related to mortgage rates, fell for three consecutive days to 3.16131%, a decrease of 15.369 basis points, reaching an eight-week low.
The three-month HIBOR, which reflects bank funding costs, fell by 7.53 basis points to 3.45286%. On the longer end of the yield curve, the six-month HIBOR dropped by 2.416 basis points to 3.39191%, while the one-year rate fell by 2.917 basis points to 3.35702%.
Related Articles

Panic-driven fund frenzy for US Treasury bonds, strategists betting on yields falling to 3.8%

The hidden worries in the US credit market have not disappeared, with BDC financial reports becoming a "risk examination report".

Saudia Aramco bets on AI transformation: creating the world's third largest artificial intelligence powerhouse with cheap energy
Panic-driven fund frenzy for US Treasury bonds, strategists betting on yields falling to 3.8%

The hidden worries in the US credit market have not disappeared, with BDC financial reports becoming a "risk examination report".

Saudia Aramco bets on AI transformation: creating the world's third largest artificial intelligence powerhouse with cheap energy

RECOMMEND

World’s largest oil company Aramco posts higher Q3 net profit after lifting output
04/11/2025

HSBC, General Atlantic CEOs flag AI capex-revenue mismatch, ‘irrational exuberance’
04/11/2025

Pfizer Files Second Lawsuit Against Novo Nordisk and Metsera Amid Intensifying Bidding Battle Over Obesity Biotech
04/11/2025


